These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28665674)

  • 1. An oncologist's perspective: preparation for new payment models in cancer care.
    Apte SM
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP169-SP172. PubMed ID: 28665674
    [No Abstract]   [Full Text] [Related]  

  • 2. Making sense of advanced payment models.
    McAneny B; Grubbs SS; Birch W; Sayam Zuckerman D
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP199-SP200. PubMed ID: 28665679
    [No Abstract]   [Full Text] [Related]  

  • 3. Hope and some skepticism whether oncology payment models will work.
    Inserro A
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP350-SP351. PubMed ID: 31860254
    [No Abstract]   [Full Text] [Related]  

  • 4. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 5. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
    Shah S; Reh G
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
    [No Abstract]   [Full Text] [Related]  

  • 6. Squaring value-based payment with innovation in oncology.
    Caffrey M
    Am J Manag Care; 2018 Oct; 24(12 Spec No.):SP482-SP484. PubMed ID: 30550253
    [No Abstract]   [Full Text] [Related]  

  • 7. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 8. Why oncologists need technology to succeed in alternative payment models.
    Fargnoli B; Holleran R; Kolodziej M
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of treating cancer patients: treatments versus reimbursements.
    Goldstein MG
    Md Med; 2011; 12(4):15. PubMed ID: 22455202
    [No Abstract]   [Full Text] [Related]  

  • 10. A conversation with Lee N. Newcomer, MD, MHA. Payments with purpose. Interview by John Marcille.
    Newcomer LN
    Manag Care; 2011 Dec; 20(12):36-40. PubMed ID: 22259875
    [No Abstract]   [Full Text] [Related]  

  • 11. Are centers and practices implementing changes to their reimbursement or payment models? An NCCN Trends report.
    Guinto JB
    J Natl Compr Canc Netw; 2013 Jul; 11(7):904-5. PubMed ID: 23847223
    [No Abstract]   [Full Text] [Related]  

  • 12. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.
    Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H
    Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415
    [No Abstract]   [Full Text] [Related]  

  • 13. The long battle over payment for oncology services in the office setting.
    Bailes JS; Coleman TS
    J Oncol Pract; 2014 Jan; 10(1):1-4. PubMed ID: 24443726
    [No Abstract]   [Full Text] [Related]  

  • 14. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promise and peril: cancer care.
    Galloro V
    Mod Healthc; 2001 Jun; 31(25):74-6. PubMed ID: 11436393
    [No Abstract]   [Full Text] [Related]  

  • 16. AAFP challenges payment inequities in primary care, oncology initiatives.
    Am Fam Physician; 2015 May; 91(9):598. PubMed ID: 25955732
    [No Abstract]   [Full Text] [Related]  

  • 17. State of Cancer Care in America: Reflections on an Inaugural Year.
    Polite BN; Seid JE; Freeman M; Levit LA; Kirkwood MK; Schenkel C; Bruinooge SS; Schilsky RL
    J Oncol Pract; 2019 Apr; 15(4):163-165. PubMed ID: 30856037
    [No Abstract]   [Full Text] [Related]  

  • 18. Reforming the payment system for medical oncology.
    Bach PB
    JAMA; 2013 Jul; 310(3):261-2. PubMed ID: 23817729
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidance of healthcare development for metastatic cancer patients as an example for setting incentives.
    Haier J; Sleeman J; Schäfers J
    Clin Exp Metastasis; 2020 Feb; 37(1):1-5. PubMed ID: 31845033
    [No Abstract]   [Full Text] [Related]  

  • 20. Debating the oncologist's role in defining the value of cancer care: we have a duty to society.
    Jagsi R
    J Clin Oncol; 2014 Dec; 32(36):4035-8. PubMed ID: 25422489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.